Senior insider sale
President and CEO at VERA THERAPEUTICS, INC. — senior position signals high conviction
$2.55M
61.58K shares
What this filing means
FORDYCE MARSHALL plans to sell 61.58K shares of VERA THERAPEUTICS, INC. valued at approximately $2.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/26/2025ACC: 0001950047-25-001279
DirectorOfficer· President and CEO
Since May 2021
61.58K
Shares to sell
$2.55M
Approx. market value
9.07K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
2/20/2025
9.07KTotal acquired9.07K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/20/2025 | Restricted Stock Units N/A | 9.07K | — |
| Total | 9.07K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
17.50K
Market value
$730.5K
1/8/2025
—Completed
Units to sell
17.50K
Market value
$753.7K
12/18/2024
—Completed
Units to sell
17.50K
Market value
$821.5K
12/11/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.07K
Market value
$245.9K
2/26/2025
Total
Units
61.58K
Value
$2.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/8/2025 | 17.50K | $730.5K | — | Completed |
12/18/2024 | 17.50K | $753.7K | — | Completed |
12/11/2024 | 17.50K | $821.5K | — | Completed |
| Planned — Approximate Date | ||||
2/26/2025 | 9.07K | $245.9K | NASDAQ | Planned |
| Total | 61.58K | $2.55M | ||